Elanco Animal Health Incorporated ELAN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -147.00M | -199.00M | -242.00M | -232.00M | 36.00M |
| Total Depreciation and Amortization | 670.00M | 667.00M | 663.00M | 649.00M | 635.00M |
| Total Amortization of Deferred Charges | 24.00M | 26.00M | 28.00M | 31.00M | 35.00M |
| Total Other Non-Cash Items | 112.00M | 78.00M | 55.00M | 13.00M | -7.00M |
| Change in Net Operating Assets | -45.00M | 45.00M | 73.00M | 99.00M | -70.00M |
| Cash from Operations | 614.00M | 617.00M | 577.00M | 560.00M | 629.00M |
| Capital Expenditure | -206.00M | -238.00M | -262.00M | -276.00M | -261.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -76.00M | -76.00M | -- | -- | -41.00M |
| Divestitures | 0.00 | 0.00 | 0.00 | 9.00M | 9.00M |
| Other Investing Activities | -14.00M | -21.00M | -19.00M | -12.00M | -12.00M |
| Cash from Investing | -296.00M | -335.00M | -281.00M | -279.00M | -305.00M |
| Total Debt Issued | 2.16B | 2.45B | 2.40B | 2.65B | 540.00M |
| Total Debt Repaid | -2.46B | -2.43B | -2.76B | -2.92B | -850.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -36.00M | -35.00M | -35.00M | -14.00M | -14.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -32.00M | -287.00M | 4.00M | 12.00M | 35.00M |
| Cash from Financing | -373.00M | -310.00M | -392.00M | -275.00M | -289.00M |
| Foreign Exchange rate Adjustments | 15.00M | 19.00M | 37.00M | 71.00M | -20.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.00M | -9.00M | -59.00M | 77.00M | 15.00M |